APTBIO

About:

APTBIO is a proteomic technology firm.

Website: http://www.aptbiotech.com/

Top Investors: Legend Capital, GF Xinde Investment Management, Lucion, Wuxi New District Investment Group, Sun Rock Capital

Description:

APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

Total Funding Amount:

$28.3M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2004-01-01

Founders:

Wei Chen

Number of Employees:

51-100

Last Funding Date:

2024-04-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai